Kevin Crossley

Kevin Crossley is a scientist in the Synthetic Separations group at Amgen with 23 years of pharmaceutical industry experience in purification and chromatography. He began his career with largescale natural product isolations and joined Amgen in 2008, supporting programs from FIH to commercial with chiral and achiral purifications. Since 2019, he has contributed to advancing the Discovery pipeline and purification capabilities. Kevin is a recipient of multiple green chemistry awards, holds patents, and has authored several publications.